Katy Rezvani, M.D., Ph.D. (IMAGE)

University of Texas M. D. Anderson Cancer Center

Katy Rezvani, M.D., Ph.D.

Caption

A Phase II trial at MD Anderson tound that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma.

Credit

MD Anderson Cancer Center

Usage Restrictions

One-time only permission granted.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.